desipramine has been researched along with ADDH in 68 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 6-week randomized, double-blind, placebo controlled trial of desipramine (DMI) in daily doses averaging 4 to 5 mg/kg for the treatment of children and adolescents with attention deficit disorder with hyperactivity (ADDH) was further analyzed." | 5.07 | A double-blind placebo controlled study of desipramine in the treatment of ADD: III. Lack of impact of comorbidity and family history factors on clinical response. ( Baldessarini, RJ; Biederman, J; Faraone, S; Keenan, K; Wright, V, 1993) |
| "The tricyclic antidepressant drug desipramine (DMI) was evaluated in the treatment of young patients with attention deficit disorder with hyperactivity (ADDH) in an unselected sample of 62 clinically referred patients, 43 (69%) of whom previously responded poorly to psychostimulant treatment." | 5.06 | A double-blind placebo controlled study of desipramine in the treatment of ADD: I. Efficacy. ( Baldessarini, RJ; Biederman, J; Harmatz, JS; Knee, D; Wright, V, 1989) |
| "In a 6-week study of children and adolescents with attention deficit disorder with hyperactivity (ADDH) in which desipramine (DMI) was highly effective and well tolerated, the mean maximal daily oral dose in the DMI-treated patients (N = 31) was 4." | 5.06 | A double-blind placebo controlled study of desipramine in the treatment ADD: II. Serum drug levels and cardiovascular findings. ( Baldessarini, RJ; Biederman, J; Goldblatt, A; Harmatz, JS; Knee, D; Wright, V, 1989) |
| "Treatment with desipramine (mean total daily dose, 3." | 2.70 | A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder. ( Bearman, SK; Biederman, J; Coffey, B; Crawford, M; Faraone, SV; Geller, D; Spencer, T; Tarazi, R, 2002) |
| " Side effect ratings and EKGs were done weekly." | 2.67 | Side effects of methylphenidate and desipramine alone and in combination in children. ( Biancaniello, TM; Carlson, GA; Kelly, KL; Pataki, CS; Rapport, MD, 1993) |
| "Desipramine is a tricyclic antidepressant with demonstrated efficacy for some children with attention deficit hyperactivity disorder (ADHD)." | 2.67 | Clinical and neuropsychological effects of desipramine in children with attention deficit hyperactivity disorder. ( Chandler, M; Gualtieri, CT; Keenan, PA, 1991) |
| "The imipramine dosage was significantly higher in the combined treatment group than in the imipramine-only group." | 2.67 | Possible influence of carbamazepine on plasma imipramine concentrations in children with attention deficit hyperactivity disorder. ( Brown, CS; Cold, JA; Froemming, JH; Jabbour, JT; Self, TH; Wells, BG, 1990) |
| "Twelve adolescents with attention deficit disorder were treated with desipramine in an open trial to assess its efficacy and safety." | 2.65 | Desipramine in the treatment of adolescents with attention deficit disorder. ( Biederman, J; Gastfriend, DR; Jellinek, MS, 1984) |
| " In one study, tics limited further dosage increases of methylphenidate." | 2.58 | Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders. ( Osland, ST; Pringsheim, T; Steeves, TD, 2018) |
| "Desipramine and placebo were similar on "all-cause treatment discontinuation" (RD -0." | 2.50 | Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents. ( Castells, X; Ehimare, UP; Otasowie, J; Smith, CH, 2014) |
| " Adverse effects were evaluated as well." | 2.49 | A systematic review of the efficacy and safety of desipramine for treating ADHD. ( Ghanizadeh, A, 2013) |
| "Only treatment with bupropion seems to have a medium-range effect size, but this is less than that of stimulant medications." | 2.45 | Antidepressants in the treatment of adult attention-deficit hyperactivity disorder: a systematic review. ( Bekkering, GE; Tuinier, S; Verbeeck, W, 2009) |
| " This review focuses on the tolerability, occurrence of adverse events, precautions required to prevent severe adverse events, and essential pharmacological interaction in the treatment of ADHD symptoms by non-stimulants." | 2.43 | The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder. ( Banaschewski, T; Heise, CA; Himpel, S; Rothenberger, A, 2005) |
| " Thirty-two reports (29 studies) evaluated adverse effects of drug therapy; many of the side effects associated with stimulant use appear to be relatively mild and of short duration and to respond to dosing or timing adjustments." | 2.40 | Treatment of attention-deficit/hyperactivity disorder. ( Boyle, M; Cunningham, C; Jadad, AR; Kim, M; Schachar, R, 1999) |
| " Included are the drugs' putative mechanisms of action, pharmacology, toxicology, indications for their use, short-term and long-term actions, adverse effects, specific dosing regimens, therapeutic monitoring techniques, alternative medications, and drug interactions." | 2.38 | Pharmacologic treatment of attention deficit hyperactivity disorder. ( Greenhill, LL, 1992) |
| "Because in many patients with Tourette's syndrome (TS) the ADHD symptoms are the major source of disability, alternative nonstimulant treatments are needed." | 1.29 | Bupropion exacerbates tics in children with attention-deficit hyperactivity disorder and Tourette's syndrome. ( Biederman, J; Spencer, T; Steingard, R; Wilens, T, 1993) |
| "As many as 50% of patients with Tourette's syndrome (TS) also meet diagnostic criteria for attention-deficit hyperactivity disorder (ADHD)." | 1.29 | Desipramine treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome. ( Biederman, J; Kerman, K; Spencer, T; Steingard, R; Wilens, T, 1993) |
| "No significant arrhythmias or tachycardias were observed." | 1.29 | ECG changes in pediatric patients on tricyclic antidepressants, desipramine, and imipramine. ( Giuffre, RM; Johnson, A; O'Malley, K, 1996) |
| "There have been additional reports of sudden death in children." | 1.28 | Sudden death in children receiving Norpramin: a review of three reported cases and commentary. ( Cohen, DJ; King, RA; Kleinman, CS; Leckman, JF; Nelson, JC; Rasmusson, A; Riddle, MA, 1991) |
| "Therapy for Tourette's syndrome with tricyclic antidepressants has had varied results." | 1.27 | A case of Tourette's syndrome with symptoms of attention deficit disorder treated with desipramine. ( Biederman, J; Hoge, SK, 1986) |
| "Eighteen children with attention deficit disorder were treated with desipramine in a prospective open trial to assess its efficacy and safety." | 1.27 | Desipramine in the treatment of children with attention deficit disorder. ( Biederman, J; Gastfriend, DR; Jellinek, MS, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (25.00) | 18.7374 |
| 1990's | 28 (41.18) | 18.2507 |
| 2000's | 15 (22.06) | 29.6817 |
| 2010's | 8 (11.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Osland, ST | 1 |
| Steeves, TD | 1 |
| Pringsheim, T | 1 |
| Villas-Boas, CB | 1 |
| Chierrito, D | 1 |
| Fernandez-Llimos, F | 1 |
| Tonin, FS | 1 |
| Sanches, ACC | 1 |
| Ghanizadeh, A | 1 |
| Preskorn, SH | 1 |
| Otasowie, J | 1 |
| Castells, X | 1 |
| Ehimare, UP | 1 |
| Smith, CH | 1 |
| Buoli, M | 1 |
| Serati, M | 1 |
| Cahn, W | 1 |
| Spencer, TJ | 5 |
| Verbeeck, W | 1 |
| Tuinier, S | 1 |
| Bekkering, GE | 1 |
| Bizot, JC | 1 |
| David, S | 1 |
| Trovero, F | 1 |
| Hiraide, S | 1 |
| Ueno, K | 1 |
| Yamaguchi, T | 1 |
| Matsumoto, M | 1 |
| Yanagawa, Y | 1 |
| Yoshioka, M | 1 |
| Togashi, H | 1 |
| Daley, KC | 1 |
| Overtoom, CC | 1 |
| Verbaten, MN | 1 |
| Kemner, C | 1 |
| Kenemans, JL | 1 |
| van Engeland, H | 1 |
| Buitelaar, JK | 1 |
| van der Molen, MW | 1 |
| van der Gugten, J | 1 |
| Westenberg, H | 1 |
| Maes, RA | 1 |
| Koelega, HS | 1 |
| Kanbayashi, Y | 1 |
| Gasior, M | 1 |
| Bergman, J | 1 |
| Kallman, MJ | 1 |
| Paronis, CA | 1 |
| Wilens, TE | 7 |
| Hammerness, PG | 1 |
| Biederman, J | 23 |
| Kwon, A | 1 |
| Clark, S | 1 |
| Scott, M | 1 |
| Podolski, A | 1 |
| Ditterline, JW | 1 |
| Morris, MC | 1 |
| Moore, H | 1 |
| Himpel, S | 1 |
| Banaschewski, T | 1 |
| Heise, CA | 1 |
| Rothenberger, A | 1 |
| Rains, A | 1 |
| Scahill, L | 1 |
| Hamrin, V | 1 |
| Slatkoff, J | 1 |
| Greenfield, B | 1 |
| Gastfriend, DR | 3 |
| Jellinek, MS | 4 |
| Garfinkel, BD | 1 |
| Wender, PH | 1 |
| Sloman, L | 1 |
| O'Neill, I | 1 |
| Werry, JS | 1 |
| Thisted, R | 1 |
| Greenhill, L | 2 |
| Ryan, N | 1 |
| Alderton, HR | 1 |
| Singer, HS | 1 |
| Brown, J | 1 |
| Quaskey, S | 1 |
| Rosenberg, LA | 1 |
| Mellits, ED | 1 |
| Denckla, MB | 1 |
| Mick, E | 2 |
| Walsh, BT | 1 |
| Giardina, EG | 1 |
| Sloan, RP | 1 |
| Goldfein, J | 1 |
| Baldessarini, RJ | 6 |
| Puopolo, PR | 2 |
| Flood, JG | 2 |
| Goldblatt, A | 3 |
| Lapey, KA | 1 |
| Doyle, A | 1 |
| Hesslein, PS | 1 |
| Pataki, CS | 1 |
| Carlson, GA | 2 |
| Kelly, KL | 2 |
| Rapport, MD | 2 |
| Biancaniello, TM | 1 |
| Wright, V | 5 |
| Keenan, K | 1 |
| Faraone, S | 1 |
| Spencer, T | 6 |
| Steingard, R | 2 |
| Wilens, T | 3 |
| Pataki, C | 1 |
| Kerman, K | 1 |
| Johnson, A | 1 |
| Giuffre, RM | 1 |
| O'Malley, K | 1 |
| Prince, J | 1 |
| Faraone, SV | 5 |
| Warburton, R | 1 |
| Schleifer, D | 1 |
| Harding, M | 1 |
| Linehan, C | 1 |
| Geller, D | 2 |
| Colson, ER | 1 |
| Higgins, ES | 1 |
| Jadad, AR | 1 |
| Boyle, M | 1 |
| Cunningham, C | 1 |
| Kim, M | 1 |
| Schachar, R | 1 |
| Seidman, LJ | 1 |
| Doyle, AE | 1 |
| Treisman, GJ | 1 |
| Angelino, AF | 1 |
| Hutton, HE | 1 |
| Coffey, B | 1 |
| Crawford, M | 1 |
| Bearman, SK | 1 |
| Tarazi, R | 1 |
| Millichap, JG | 1 |
| Greenhill, LL | 1 |
| Holt, KG | 1 |
| McDermott, SP | 1 |
| Magee, R | 1 |
| Maier, D | 1 |
| Reesal, RT | 1 |
| Danon, M | 1 |
| Tingelstad, JB | 1 |
| Riddle, MA | 2 |
| Nelson, JC | 1 |
| Kleinman, CS | 1 |
| Rasmusson, A | 1 |
| Leckman, JF | 2 |
| King, RA | 1 |
| Cohen, DJ | 1 |
| Gualtieri, CT | 1 |
| Keenan, PA | 1 |
| Chandler, M | 1 |
| Brown, CS | 1 |
| Wells, BG | 1 |
| Cold, JA | 1 |
| Froemming, JH | 1 |
| Self, TH | 1 |
| Jabbour, JT | 1 |
| Schroeder, JS | 1 |
| Mullin, AV | 1 |
| Elliott, GR | 1 |
| Steiner, H | 1 |
| Nichols, M | 1 |
| Gordon, A | 1 |
| Paulos, M | 1 |
| Knee, D | 2 |
| Harmatz, JS | 2 |
| Varley, CK | 1 |
| Gonzalez, E | 1 |
| Bronstein, B | 1 |
| De Monaco, H | 1 |
| Iwasaki, T | 1 |
| Takasuna, M | 1 |
| Hardin, MT | 1 |
| Cho, SC | 1 |
| Woolston, JL | 1 |
| Rosenbaum, JF | 1 |
| Pollack, MH | 1 |
| Hoge, SK | 1 |
| Linet, LS | 1 |
| Rapoport, JL | 1 |
| Zametkin, A | 1 |
| Donnelly, M | 1 |
| Ismond, D | 1 |
| Gastfriend, D | 1 |
18 reviews available for desipramine and ADDH
| Article | Year |
|---|---|
Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervou | 2018 |
Pharmacological treatment of attention-deficit hyperactivity disorder comorbid with an anxiety disorder: a systematic review.
Topics: Adolescent; Adult; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyp | 2019 |
A systematic review of the efficacy and safety of desipramine for treating ADHD.
Topics: Adolescent; Animals; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity | 2013 |
Clinical psychopharmacology and medical malpractice: the four Ds.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; C | 2014 |
Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Central | 2014 |
Alternative pharmacological strategies for adult ADHD treatment: a systematic review.
Topics: Adrenergic alpha-Agonists; Adult; Amphetamines; Antidepressive Agents; Attention Deficit Disorder wi | 2016 |
Antidepressants in the treatment of adult attention-deficit hyperactivity disorder: a systematic review.
Topics: Adrenergic Uptake Inhibitors; Adult; Age Factors; Antidepressive Agents; Antidepressive Agents, Tric | 2009 |
[Attention deficit/hyperactivity disorder].
Topics: Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Central Nervous Sys | 2003 |
The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder.
Topics: Adrenergic alpha-Agonists; Adult; Antidepressive Agents, Tricyclic; Atomoxetine Hydrochloride; Atten | 2005 |
Pharmacological treatment of attention-deficit/hyperactivity disorder in adults.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Tricyclic; Atomoxetine Hydrochloride; At | 2006 |
Tricyclic medication in children and the QT interval: case report and discussion.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Chil | 1995 |
Adults with attention-deficit/hyperactivity disorder: a controversial diagnosis.
Topics: Adolescent; Adult; Age Factors; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit | 1998 |
A comparative analysis of antidepressants and stimulants for the treatment of adults with attention-deficit hyperactivity disorder.
Topics: Adult; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Central Nerv | 1999 |
Treatment of attention-deficit/hyperactivity disorder.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Tricyclic; Attention Deficit Disorder wi | 1999 |
Attention-deficit/hyperactivity disorder in adults: an overview.
Topics: Adult; Age Factors; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; | 2000 |
Pharmacologic treatment of attention deficit hyperactivity disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Pres | 1992 |
A review of studies of drug treatment efficacy for attention deficit disorder with hyperactivity in adolescents.
Topics: Adolescent; Adult; Attention; Attention Deficit Disorder with Hyperactivity; Central Nervous System | 1985 |
New drug trials in attention deficit disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Clinical Trials as Topic; Clorgyline; Desipram | 1985 |
15 trials available for desipramine and ADDH
| Article | Year |
|---|---|
Effects of methylphenidate, desipramine, and L-dopa on attention and inhibition in children with Attention Deficit Hyperactivity Disorder.
Topics: Attention; Attention Deficit Disorder with Hyperactivity; Child; Choice Behavior; Desipramine; Dopam | 2003 |
Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder.
Topics: Adult; Amphetamines; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Blood Pre | 2005 |
Desipramine in the treatment of adolescents with attention deficit disorder.
Topics: Adolescent; Ambulatory Care; Attention Deficit Disorder with Hyperactivity; Child; Clinical Trials a | 1984 |
The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine.
Topics: Adolescent; Analysis of Variance; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; D | 1995 |
Side effects of methylphenidate and desipramine alone and in combination in children.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Comorbidity; Depressive Disorder; | 1993 |
A double-blind placebo controlled study of desipramine in the treatment of ADD: III. Lack of impact of comorbidity and family history factors on clinical response.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Child Behavior Disorders; Comorbid | 1993 |
Methylphenidate and desipramine in hospitalized children: I. Separate and combined effects on cognitive function.
Topics: Arousal; Attention; Attention Deficit Disorder with Hyperactivity; Child; Depressive Disorder; Desip | 1993 |
Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder.
Topics: Adolescent; Adult; Age Factors; Ambulatory Care; Anxiety Disorders; Attention Deficit Disorder with | 1996 |
A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder.
Topics: Adolescent; Age Factors; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperacti | 2002 |
Clinical and neuropsychological effects of desipramine in children with attention deficit hyperactivity disorder.
Topics: Affect; Attention Deficit Disorder with Hyperactivity; Behavior; Child; Desipramine; Double-Blind Me | 1991 |
Possible influence of carbamazepine on plasma imipramine concentrations in children with attention deficit hyperactivity disorder.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Carbamazepine; Child; Child, Preschool; D | 1990 |
Cardiovascular effects of desipramine in children.
Topics: Arrhythmias, Cardiac; Attention Deficit Disorder with Hyperactivity; Child; Clinical Trials as Topic | 1989 |
A double-blind placebo controlled study of desipramine in the treatment of ADD: I. Efficacy.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Desipramine; Dose-Response Relatio | 1989 |
A double-blind placebo controlled study of desipramine in the treatment ADD: II. Serum drug levels and cardiovascular findings.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Cardiovascular System; Child; Desipramine | 1989 |
New drug trials in attention deficit disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Clinical Trials as Topic; Clorgyline; Desipram | 1985 |
36 other studies available for desipramine and ADDH
| Article | Year |
|---|---|
Treatment of adult ADHD and comorbid depression.
Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; | 2008 |
Effects of atomoxetine, desipramine, d-amphetamine and methylphenidate on impulsivity in juvenile rats, measured in a T-maze procedure.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hy | 2011 |
Behavioural effects of monoamine reuptake inhibitors on symptomatic domains in an animal model of attention-deficit/hyperactivity disorder.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Biogenic Monoamines; Desip | 2013 |
Updates on attention deficit hyperactivity disorder, child abuse and neglect, and sudden infant death syndrome.
Topics: Adrenergic Uptake Inhibitors; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder wi | 2003 |
Evaluation of the reinforcing effects of monoamine reuptake inhibitors under a concurrent schedule of food and i.v. drug delivery in rhesus monkeys.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hy | 2005 |
Nonstimulant medications for the treatment of ADHD.
Topics: Adrenergic alpha-Agonists; Antidepressive Agents, Tricyclic; Atomoxetine Hydrochloride; Attention De | 2006 |
Tricyclic antidepressant and methylphenidate treatment of attention deficit disorder in children.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Clomipramine; Desipramine; D | 1983 |
Resolved: cardiac arrhythmias make desipramine an unacceptable choice in children.
Topics: Antidepressive Agents, Tricyclic; Arrhythmias, Cardiac; Attention Deficit Disorder with Hyperactivit | 1995 |
A systematic assessment of tricyclic antidepressants in the treatment of adult attention-deficit hyperactivity disorder.
Topics: Adult; Age Factors; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Attention Deficit Disord | 1995 |
Effects of desipramine on autonomic control of the heart.
Topics: Adolescent; Adult; Arousal; Attention Deficit Disorder with Hyperactivity; Autonomic Nervous System; | 1994 |
Electrocardiographic effects of desipramine and 2-hydroxydesipramine in children, adolescents, and adults treated with desipramine.
Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; | 1993 |
A naturalistic study of 24-hour electrocardiographic recordings and echocardiographic findings in children and adolescents treated with desipramine.
Topics: Adolescent; Arrhythmias, Cardiac; Attention Deficit Disorder with Hyperactivity; Child; Child, Presc | 1993 |
Bupropion exacerbates tics in children with attention-deficit hyperactivity disorder and Tourette's syndrome.
Topics: Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Clonidine; Desipramine; Female; Hum | 1993 |
Desipramine treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Comorbidity; Des | 1993 |
ECG changes in pediatric patients on tricyclic antidepressants, desipramine, and imipramine.
Topics: Adolescent; Alberta; Antidepressive Agents, Tricyclic; Arrhythmias, Cardiac; Attention Deficit Disor | 1996 |
Medication for children with attention disorders.
Topics: Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Child; Desipramine; | 1997 |
The drug-placebo response curve: a new method for assessing drug effects in clinical trials.
Topics: Adrenergic Uptake Inhibitors; Adult; Area Under Curve; Attention Deficit Disorder with Hyperactivity | 2000 |
Psychiatric issues in the management of patients with HIV infection.
Topics: Adult; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Depressive Disorder, Ma | 2001 |
Effectiveness of attention-deficit/hyperactivity treatment and diagnosis methods tested.
Topics: Adult; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System | 2000 |
Growth of hyperkinetic children taking methylphenidate, dextroamphetamine, or imipramine/desipramine.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Desipramine; Dextroamphetamine; Growth; Humans | 1978 |
Growth deficits and desipramine.
Topics: Appetite; Attention Deficit Disorder with Hyperactivity; Body Weight; Child; Depressive Disorder; De | 1992 |
Fluoxetine inhibits desipramine metabolism.
Topics: Attention Deficit Disorder with Hyperactivity; Depressive Disorder; Desipramine; Drug Interactions; | 1992 |
Adult attention deficit hyperactivity disorder and desipramine.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Desipramine; Dysmenorrhea; Family; Female; Hum | 1992 |
Growth deficits in children treated with desipramine: a controlled study.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Body Height; Body Weight; Child; Desipram | 1992 |
The cardiotoxicity of the tricyclics.
Topics: Antidepressive Agents, Tricyclic; Arrhythmias, Cardiac; Attention Deficit Disorder with Hyperactivit | 1991 |
Sudden death in children receiving Norpramin: a review of three reported cases and commentary.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Death, Sudden; Depressive Disorder; Desipramin | 1991 |
Sudden death in children treated with a tricyclic antidepressant.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Death, Sudden; Desipramine; Heart Diseases; Hu | 1990 |
Desipramine and cutaneous reactions in pediatric outpatients.
Topics: Adolescent; Adult; Age Factors; Ambulatory Care; Anxiety Disorders; Attention Deficit Disorder with | 1988 |
[Spontaneous motor activity and radial-maze learning in rats neonatally treated with 6-hydroxydopamine].
Topics: Animals; Animals, Newborn; Attention Deficit Disorder with Hyperactivity; Desipramine; Female; Hydro | 1986 |
Desipramine treatment of boys with attention-deficit hyperactivity disorder and tics: preliminary clinical experience.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Desipramine; Humans; Male; Tic Disorders | 1988 |
Anhedonic ejaculation with desipramine.
Topics: Attention; Attention Deficit Disorder with Hyperactivity; Depressive Disorder; Desipramine; Ejaculat | 1988 |
A case of Tourette's syndrome with symptoms of attention deficit disorder treated with desipramine.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Desipramine; Humans; Male; Tourette Syndrome | 1986 |
Tourette's syndrome with symptoms of attention deficit disorder treated with desipramine.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Desipramine; Humans; Male; Tourette Syndrome | 1987 |
Desipramine in the treatment of children with attention deficit disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Desipramine; Female; Humans; | 1986 |
Desipramine in the treatment of attention deficit disorder in adolescents.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Desipramine; Dose-Response Relatio | 1985 |
Cardiovascular effects of desipramine in children and adolescents with attention deficit disorder.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Cardiovascular System; Ch | 1985 |